Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Medtronic
Colorcon
Baxter
Teva
Daiichi Sankyo
Citi
Moodys
AstraZeneca

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,619,939

« Back to Dashboard

Summary for Patent: 4,619,939
Title: Process for reducing intraocular pressure
Abstract:Process and composition for reducing intraocular pressure and reducing aqueous humor formation by applying topically to the cornea an effective amount of an aqueous solution of a caronic anhydrase inhibitor comprising a sulfonamide having the following properties: a. sufficiently soluble in water to form at least a 3 mM solution at pH 8.2 or a pKa of not greater than 7.3; b. ether partition coefficient of at least 1.0; c. chloroform partition coefficient of at least 0.01; d. dissociation constant against carbonic anhydrase of not more than 3.times.10.sup.-8 molar; e. first order rate constant for penetration of the sulfonamide through a living rabbit cornea of at least 0.005 hr.sup.-1 ; f. not injurious to the cornea; and g. stable in aqueous solution and in contact with the cornea.
Inventor(s): Maren; Thomas H. (Gainesville, FL)
Assignee: University of Florida (Gainesville, FL)
Application Number:06/729,907
Patent Claim Types:
see list of patent claims
Use; Formulation; Process; Composition; Dosage form;

Drugs Protected by US Patent 4,619,939

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,619,939

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 13632 ➤ Subscribe
Belgium 899314 ➤ Subscribe
Canada 1192560 ➤ Subscribe
Canada 1193546 ➤ Subscribe
Switzerland 659585 ➤ Subscribe
Germany 3170818 ➤ Subscribe
Germany 3411104 ➤ Subscribe
Denmark 376281 ➤ Subscribe
European Patent Office 0044134 ➤ Subscribe
France 2560769 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Fuji
US Department of Justice
Dow
Chubb
Medtronic
Cerilliant
UBS
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot